Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages

<p>Supp Tables</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Renumathy Dhanasekaran (14962092) (author)
مؤلفون آخرون:	Aida S. Hansen (14962095) (author), Jangho Park (14962098) (author), Lea Lemaitre (14962101) (author), Ian Lai (14962104) (author), Nia Adeniji (14962107) (author), Sibu Kuruvilla (14962110) (author), Akanksha Suresh (14962113) (author), Josephine Zhang (14962116) (author), Varsha Swamy (14962119) (author), Dean W. Felsher (14962122) (author)
منشور في:	2025
الموضوعات:	Cancer Cancer Biology Immuno-oncology Immunology Immune responses to cancer Tumor-associated macrophages Immunotherapy Checkpoint blockade Combination immunotherapy Oncogenes & Tumor Suppressors Oncogenes
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
حسب: Hansol Lee (15054787)
منشور في: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
حسب: Hansol Lee (15054787)
منشور في: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
حسب: Hansol Lee (15054787)
منشور في: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
حسب: Hansol Lee (15054787)
منشور في: (2025)

Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.2 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.3 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.4 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.7 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Supplementary Figure 1 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
حسب: Francisco Exposito (16721403)
منشور في: (2025)

Supplementary Figure 2 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
حسب: Francisco Exposito (16721403)
منشور في: (2025)

Supplementary Figure 3 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
حسب: Francisco Exposito (16721403)
منشور في: (2025)

Supplementary Figure 4 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
حسب: Francisco Exposito (16721403)
منشور في: (2025)

Supplementary Figure 5 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
حسب: Francisco Exposito (16721403)
منشور في: (2025)

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Supp. Figure 1 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 2 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 3 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 4 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 5 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 6 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supplementary Table S3 from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
حسب: Shima Nakanishi (16336496)
منشور في: (2025)

Supplementary Table S4 from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
حسب: Shima Nakanishi (16336496)
منشور في: (2025)

Supplementary Table 1 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
حسب: Duygu Kuzuoglu-Ozturk (14960213)
منشور في: (2025)

Supplementary Table 2 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
حسب: Duygu Kuzuoglu-Ozturk (14960213)
منشور في: (2025)

Supplementary Table 3 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
حسب: Duygu Kuzuoglu-Ozturk (14960213)
منشور في: (2025)

Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supplementary Table S1-19 from Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations
حسب: Yuxi Liu (15293121)
منشور في: (2025)

Table 1_The CD300c antibody CL7 suppresses tumor growth by regulating the tumor microenvironment in non-small cell lung carcinoma.docx
حسب: Soyoung Kim (117362)
منشور في: (2025)

Supplementary Tables from The IGF2BP3–COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression
حسب: Jing Tang (17314958)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_549kcpdi6l90nnrnpuorgr1g0q